ArticlesCliniciansPacientsResearchersCell therapyResearchCTGCTNICRodrigo Ortiz 28 May 2025 How Ultrasound Can Control Cells, the Future of Medicine? Members of our team have already published work on sonogenetics (check our article breaking down that research here). We think this could have interesting applications in the future, since it overcomes the issue of ... More
EventsCliniciansPacientsResearchersATMPsCell therapyGen TherapyBusiness ModelMarketaccessCTGCTNICGregor Cuzak 20 May 2025 Event Date: 1 May 2025 do: 31 May 2025 • Posters at Krakovski nasip – Ljubljanica embankment In May 2025, our Centre for the Technologies of Gene and Cell Therapy CTGCT) is participating in a poster exhibition on Krakovski nasip, as part of the Chemical Institute’s public presentation. More
EventsCliniciansPacientsResearchersCharite BerlinCTGCTNICTUDUCLUMCUtrechtRodrigo Ortiz 19 May 2025 Event Date: 15 May 2025 do: 15 May 2025 • Review meeting of Reporting Period 1 for the CTGCT On May 15, 2024, the members of the CTGCT hosted the review meeting for the Reporting Period 1of its EU-funded project at the Kemijski Inštitut in Ljubljana, in collaboration with representatives from its Advanced Partners More
ArticlesEventsCliniciansPacientsResearchersGen TherapyRaziskaveCTGCTNICRodrigo Ortiz 8 April 2025 Event Date: 21 March 2025 do: 21 March 2025 • CTGCT’s Role in the GeneH Project: Accelerating Gene Therapy Innovations We are thrilled to announce our participation in the GeneH consortium, an ambitious project led by the University of Coimbra, and their GeneT project, colead by the Kemijski Inštitut with the CTGCT project, aimed ... More
EventsPacientsBusiness ModelInvestmentCTGCTNICRodrigo Ortiz 13 March 2025 Event Date: 12 March 2025 do: 12 March 2025 • Prime Minister of Slovenia Dr. Robert Golob visits the Kemijski Inštitut to discuss the CTGCT plans Yesterday, Dr. Robert Golob, Prime Minister of the Slovenian Government, visited the Kemijski inštitut - National Institute of Chemistry. More
EventsResearchersGLPGMPDrug DiscoveryLaboratoryResearchCTGCTNICGregor Cuzak 3 March 2025 Event Date: 10 February 2025 − Workshop Report: Introduction to 4D-Nucleofector Technology A hands-on workshop on 4D-Nucleofector technology provided insights into gene transfer using Lonza’s Core- and X units. Participants learned about nucleofection, optimized protocols, and best practices for efficient gene delivery in cell-based research. More
ArticlesPacientsATMPsCell therapyGen TherapyBusiness ModelEconomicsPre ClinicalResearchCTGCTNICRodrigo Ortiz 28 February 2025 How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ... More
ArticlesCliniciansPacientsResearchersATMPsCell therapyResearchCTGCTNICRodrigo Ortiz 25 February 2025 Controlling Cells With Chemically Switchable Antibodies: A New Opportunity For Precision Therapy Imagine being able to turn a cell’s behavior ON or OFF, just like flipping a light switch. That’s exactly what scientists have achieved with the innovative technology presented in this paper published in the ... More
ArticlesPacientsResearchersGen TherapyLaboratoryPre ClinicalResearchCTGCTNICRodrigo Ortiz 28 January 2025 The research on combining cytokines with pyroptosis is gaining widespread media coverage Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week". More
Media ReleasesCliniciansPacientsResearchersATMPsEconomicsResearchCTGCTNICGregor Cuzak 22 January 2025 Slovenia Joins ERDERA to Advance Rare Disease Research and Collaboration CTGCT welcomes Slovenia's entry into the European Research Partnership for Rare Diseases ERDERA More
Media ReleasesPacientsResearchCTGCTNICRodrigo Ortiz 10 January 2025 Head of CTGCT research selected as breakthrough discovery by the national TV in Slovenia Check this video were he Head of the #CTGCT prof. dr. Mojca Benčina appeared in the news of the Slovenian national TV since her researched was selected as one of the breakthrough discoveries by ... More
ArticlesCliniciansPacientsCell therapyGen TherapyLaboratoryPre ClinicalResearchCTGCTNICRodrigo Ortiz 7 January 2025 Combining cytokines and pyroptosis, a promising weapon against cancer A recent study published in Nature Communications has unveiled a groundbreaking approach that combines the power of cytokines with a type of cell death called pyroptosis to boost the immune system's ability to fight ... More
